(CBS) – A drug that is commonly used to treat men with enlarged prostates may also delay the growth of prostate cancer, according to a new study.

The drug, dutasteride, works by blocking the conversion of testosterone to dihydrotestosterone, the male sex hormone implicated in the development of prostate cancer.

READ MORE: Public Utility Commission Grills ERCOT Over Its Call For Texans To Conserve Energy This Week

For the study – published in the January 24 online edition of The Lancet – 302 men ages 48 to 82 with low-risk localized prostate cancer were assigned either once daily dutasteride or a placebo for three years. Patients were given biopsies at 18 months and three years, and given a questionnaire about cancer-related anxiety.

READ MORE: Feds Warn Against Fake COVID-19 Vaccine Cards

The results showed that treatment with dutasteride significantly delayed prostate cancer progression – 38 percent versus 48 percent progression in those given the placebo.

MORE NEWS: Tarrant County Issues Warning About Expedited Passport Scams

Click here to read more about the study.